Skip to content

Assembly Biosciences ASMB Free cash flow margin

Free cash flow margin at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
1.8%+0.9pp
ALN
Alnylam PharmaceuticalsALNY
15%+12.7pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-11,123.8%-13,374pp
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
-281.5%-119pp
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-686.5%-273pp
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-25.7%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Calculated from Assembly Biosciences’s reported figures.

Based on trailing twelve months.

The official record: Assembly Biosciences’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's free cash flow margin?
Assembly Biosciences (ASMB) reported free cash flow margin of -150% in Q3 2025.
How has Assembly Biosciences's free cash flow margin changed year-over-year?
Assembly Biosciences's free cash flow margin decreased by 286.0% year-over-year, from 80.6% to -150%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.